• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    8.900 +0.250 (+2.89%)
    Streaming Delayed Price Updated: 3:57 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CNS Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
    Via ACCESSWIRE
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension for Compliance
    Via Investor Brand Network
    CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
    Via ACCESSWIRE
    Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG
    Via AB Newswire
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures $3 Million in Registered Direct Offering
    Via Investor Brand Network
    CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
    Via ACCESSWIRE
    CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
    Via ACCESSWIRE
    CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
    Via ACCESSWIRE
    CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
     
    Via Benzinga
    Nasdaq Down 2%; US Crude Stocks Increase
     
    Via Benzinga
    Gold Moves Lower; AT&T Earnings Top Views
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
     
    Via Benzinga
    CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
    Via ACCESSWIRE
    Why CNS Pharmaceuticals (CNSP) Stock Is Up 86%
    CNS Pharmaceuticals shares are trading higher by 76% Wednesday morning. The stock faces potential delisting for not meeting Nasdaq's $1.00 bid price. 
    Via Benzinga
    Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
     
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Management, Dr. Samuel Goldlust Participate in Virtual Investor KOL Connect Segment
    Via Investor Brand Network
    Jimmy Carter Survival Thanks to Novel Cancer Immunotherapy Treatment
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum
    Via Investor Brand Network
    WHO Review Says No Link Between Mobile Phones, Brain-Cancer Development
    Via Investor Brand Network
    CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
    Via ACCESSWIRE
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
    Via Investor Brand Network
    CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect Segment
    Via Investor Brand Network
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.